Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Requa’s Charcocaps activated charcoal

Executive Summary

Data submitted "do not support the effectiveness of activated charcoal as a digestive aid ingredient for the relief of the symptoms of gastrointestinal distress," FDA says in a recent letter to the company. "Accordingly, activated charcoal cannot be reclassified to Category I based on these data." Requa had submitted a citizen petition requesting that activated charcoal be reclassified from Category III to Category I for relief of gastrointestinal distress ("The Pink Sheet" Nov. 4, 1991, T&G-11).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS020703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel